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Dear Editor,
Authors of Prevalence of high-risk human papillomavirus by cobas
4800  HPV test in urban Peru presented a cross sectional look at
high  risk HPV (HR-HPV) prevalence in Peru. The sample size is
large and the diverse urban areas sampled reﬂect a national
scope.  We  applaud the use of HPV testing to navigate existing
structural  barriers for cervical cancer screening in Peru.1
While we  realize that some data may  not have been col-
lected,  it would have been ideal to have a breakdown of HPV
prevalence  by smoking and oral contraceptive status, as well
as  sexual risk behaviors including age at ﬁrst sex, sexual
partnerships, previous sexually transmitted infections, and
consistent  condom use to examine risk factors for HR-HPV
in  the general population.
If  the authors tested for HPV, they may  be morally required
to  provide treatment due to ancillary care obligations.2 This
may  be difﬁcult with signiﬁcant barriers to treatment in Peru.1
Approximately one-third of participants in this report had a
positive HR-HPV result. It is unclear if these participants were
provided  additional testing or treatment, referred to a spe-
cialist,  or provided their HPV testing results. Sharing the HPV
testing  results with participants may  be an ethical imperative,
though  it may  cause undue stress in the absence of further
testing.
The  high cervical HR-HPV DNA prevalence (43.10%)
reported among female participants 17–29 years of age is
troubling,  pointing to needs for HPV interventions. This is
higher  than previous data from women  in the general pop-
ulation  in Peru without cervical cancer precursors (14.4%),
and  from a large study in Brazil (14.3%).3,4 Without the cytol-
ogy  result, it is unclear if the Peruvian female patients began
with  cervical abnormalities. We  can only say that the preva-
lence  of HR-HPV in this report is high, similar to that found
in  a study of Peruvian female sex workers (46.2%).5 The high
prevalence  of HR-HPV in this report provides an impetus toor ancillary  care
provide additional details of characteristics of the general pop-
ulation presented in the manuscript.
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